Enlivex Therapeutics Ltd (NASDAQ:ENLV)
North American company
Share Price Chart
- Chart currently unavailable -
Market Info - ENLV
- Market Open Price0.00
- Previous Close0.00
- Volume-
- 52w Low/High-
- Last Trade Price0.00
- Bid/Ask Price0.00
Company Info - ENLV
- Market Cap$138.540m
- SymbolNASDAQ:ENLV
- IndustryHealthcare
- SectorBiotechnology
- Currency
- ISINIL0011319527
Company Profile
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.Bioblast Pharma Ltd is a clinical stage biotechnology company. It is engaged in the identification, licensing, acquisition, development and commercialization of drugs for rare and ultra-rare genetic and metabolic diseases.
Latest ENLV news
Currently there for this company. Visit our news hub for other news .